Anti-SPRL1/ SPARCL1/ MAST 9 functional antibody

Anti-SPRL1/ SPARCL1/ MAST 9 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to SPARCL1/SPARCL1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1306-Ab-1/ GM-Tg-hg-SE1306-Ab-2Anti-Human SPARCL1 monoclonal antibodyHuman
GM-Tg-rg-SE1306-Ab-1/ GM-Tg-rg-SE1306-Ab-2Anti-Rat SPARCL1 monoclonal antibodyRat
GM-Tg-mg-SE1306-Ab-1/ GM-Tg-mg-SE1306-Ab-2Anti-Mouse SPARCL1 monoclonal antibodyMouse
GM-Tg-cynog-SE1306-Ab-1/ GM-Tg-cynog-SE1306-Ab-2Anti-Cynomolgus/ Rhesus macaque SPARCL1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1306-Ab-1/ GM-Tg-felg-SE1306-Ab-2Anti-Feline SPARCL1 monoclonal antibodyFeline
GM-Tg-cang-SE1306-Ab-1/ GM-Tg-cang-SE1306-Ab-2Anti-Canine SPARCL1 monoclonal antibodyCanine
GM-Tg-bovg-SE1306-Ab-1/ GM-Tg-bovg-SE1306-Ab-2Anti-Bovine SPARCL1 monoclonal antibodyBovine
GM-Tg-equg-SE1306-Ab-1/ GM-Tg-equg-SE1306-Ab-2Anti-Equine SPARCL1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg

Product Description

Catalog No.GM-Tg-hg-SE1306-Ab-1/ GM-Tg-hg-SE1306-Ab-2; GM-Tg-rg-SE1306-Ab-1/ GM-Tg-rg-SE1306-Ab-2;
GM-Tg-mg-SE1306-Ab-1/ GM-Tg-mg-SE1306-Ab-2; GM-Tg-cynog-SE1306-Ab-1/ GM-Tg-cynog-SE1306-Ab-2;
GM-Tg-felg-SE1306-Ab-1/ GM-Tg-felg-SE1306-Ab-2; GM-Tg-cang-SE1306-Ab-1/ GM-Tg-cang-SE1306-Ab-2;
GM-Tg-bovg-SE1306-Ab-1/ GM-Tg-bovg-SE1306-Ab-2; GM-Tg-equg-SE1306-Ab-1/ GM-Tg-equg-SE1306-Ab-2
Products NameAnti-SPARCL1 monoclonal antibody
Target NameSPARCL1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
Products descriptionPre-made anti-SPARCL1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


    Data / case study

    Click to get more Data / Case study about the product.

    Associated products

    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1306-Ag-1Recombinant multi-species SPRL1/ SPARCL1/ MAST 9 protein
    ORF Viral VectorpGMLPm001105mouse Sparcl1 Lentivirus plasmid
    ORF Viral VectorvGMLPm001105mouse Sparcl1 Lentivirus particle

    Target information

    Target IDGM-SE1306
    Target NameSPARCL1
    Gene ID8404,13602,25434,701468,478470,101096060,507537,100052928
    Gene Symbol and SynonymsEcm2,hevin,MAST 9,MAST9,PIG33,SC1,SPARCL1
    Uniprot AccessionQ14515,P24054
    Uniprot Entry NameSPRL1_HUMAN,SPRL1_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    DiseasePregnant state
    Gene EnsemblENSG00000152583
    Target ClassificationN/A

    The target: SPARCL1, gene name: SPARCL1, also named as MAST 9, MAST9, PIG33, SC1. Predicted to enable calcium ion binding activity; collagen binding activity; and extracellular matrix binding activity. Predicted to be involved in anatomical structure development and regulation of synapse organization. Located in extracellular space. [provided by Alliance of Genome Resources, Apr 2022].

    About Gmab


    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.